Long COVID: Skeptics Are Wrong, Researchers Say

THURSDAY, DECEMBER 1, 2022

Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.

Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.

Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.

Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.

To download audio file, click here.

More Like This
WHO: What China Must Do Now to Help Fight COVID Image
WHO: What China Must Do Now to Help Fight COVID
Former CDC Chief Questions U.S Reaction to Chinese COVID Outbreak  Image
Former CDC Chief Questions U.S Reaction to Chinese COVID Outbreak
Health Policy Moves in ’22 Set the Stage for New Year Image
Health Policy Moves in ’22 Set the Stage for New Year